{"id":"https://openalex.org/W4388596157","doi":"https://doi.org/10.1093/eurheartj/ehad655.2799","title":"RBD5044 - a novel anti-ApoC3 GalNAc-siRNA drug resulted in sustained and profound reduction of triglycerides in mice and Rhesus monkeys","display_name":"RBD5044 - a novel anti-ApoC3 GalNAc-siRNA drug resulted in sustained and profound reduction of triglycerides in mice and Rhesus monkeys","publication_year":2023,"publication_date":"2023-11-01","ids":{"openalex":"https://openalex.org/W4388596157","doi":"https://doi.org/10.1093/eurheartj/ehad655.2799"},"language":"en","primary_location":{"id":"doi:10.1093/eurheartj/ehad655.2799","doi":"https://doi.org/10.1093/eurheartj/ehad655.2799","is_oa":true,"landing_page_url":"https://doi.org/10.1093/eurheartj/ehad655.2799","pdf_url":"https://academic.oup.com/eurheartj/article-pdf/44/Supplement_2/ehad655.2799/53609648/ehad655.2799.pdf","source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/eurheartj/article-pdf/44/Supplement_2/ehad655.2799/53609648/ehad655.2799.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102018489","display_name":"Shan Gao","orcid":"https://orcid.org/0000-0002-1603-0883","observed_orcids":["https://orcid.org/0000-0002-1603-0883"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Gao","raw_affiliation_strings":["Suzhou Ribo Life Science Co., Ltd. , Beijing , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suzhou Ribo Life Science Co., Ltd. , Beijing , China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069130770","display_name":"Hao Luo","orcid":"https://orcid.org/0000-0002-2321-9924","observed_orcids":["https://orcid.org/0000-0002-2321-9924"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Luo","raw_affiliation_strings":["Suzhou Ribo Life Science Co., Ltd. , Beijing , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suzhou Ribo Life Science Co., Ltd. , Beijing , China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100329590","display_name":"Zhen Guo","orcid":"https://orcid.org/0000-0003-4022-7755","observed_orcids":["https://orcid.org/0000-0003-4022-7755"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z Guo","raw_affiliation_strings":["Suzhou Ribo Life Science Co., Ltd. , Beijing , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suzhou Ribo Life Science Co., Ltd. , Beijing , China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"S Zheng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Zheng","raw_affiliation_strings":["Suzhou Ribo Life Science Co., Ltd. , Beijing , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suzhou Ribo Life Science Co., Ltd. , Beijing , China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"J Wikstrom","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Wikstrom","raw_affiliation_strings":["Ribocure Pharmaceuticals AB , Gothenburg , Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ribocure Pharmaceuticals AB , Gothenburg , Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084687544","display_name":"Hongyong Cao","orcid":"https://orcid.org/0000-0003-1188-991X","observed_orcids":["https://orcid.org/0000-0003-1188-991X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Cao","raw_affiliation_strings":["Suzhou Ribo Life Science Co., Ltd. , Beijing , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suzhou Ribo Life Science Co., Ltd. , Beijing , China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"H Yu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Yu","raw_affiliation_strings":["Suzhou Ribo Life Science Co., Ltd. , Beijing , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suzhou Ribo Life Science Co., Ltd. , Beijing , China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"C Tong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Tong","raw_affiliation_strings":["Suzhou Ribo Life Science Co., Ltd. , Beijing , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suzhou Ribo Life Science Co., Ltd. , Beijing , China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"H Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Zhang","raw_affiliation_strings":["Suzhou Ribo Life Science Co., Ltd. , Beijing , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suzhou Ribo Life Science Co., Ltd. , Beijing , China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Z Liang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z Liang","raw_affiliation_strings":["Suzhou Ribo Life Science Co., Ltd. , Beijing , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suzhou Ribo Life Science Co., Ltd. , Beijing , China","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"L Gan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Gan","raw_affiliation_strings":["Suzhou Ribo Life Science Co., Ltd. , Beijing , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suzhou Ribo Life Science Co., Ltd. , Beijing , China","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4238,"currency":"EUR","value_usd":4584},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"44","issue":"Supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.5151000022888184,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.5151000022888184,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.454800009727478,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.023399999365210533,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apolipoprotein-c-iii","display_name":"apolipoprotein C-III","score":0.8320000171661377},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.9039999842643738},{"id":"https://openalex.org/keywords/triglyceride-lowering","display_name":"triglyceride lowering","score":0.902999997138977},{"id":"https://openalex.org/keywords/rna-interference","display_name":"RNA interference","score":0.6779999732971191},{"id":"https://openalex.org/keywords/rhesus-macaques","display_name":"rhesus monkeys","score":0.6919999718666077},{"id":"https://openalex.org/keywords/preclinical-toxicology","display_name":"preclinical toxicology","score":0.6940000057220459},{"id":"https://openalex.org/keywords/repeated-dose-toxicity","display_name":"repeated-dose toxicity","score":0.7350000143051147}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.842179536819458},{"id":"https://openalex.org/C2776919658","wikidata":"https://www.wikidata.org/wiki/Q1467339","display_name":"Hypertriglyceridemia","level":4,"score":0.8303279876708984},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6505739092826843},{"id":"https://openalex.org/C141035611","wikidata":"https://www.wikidata.org/wiki/Q5532934","display_name":"Genetically modified mouse","level":4,"score":0.42773494124412537},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.351446270942688},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3375314474105835},{"id":"https://openalex.org/C102230213","wikidata":"https://www.wikidata.org/wiki/Q430117","display_name":"Transgene","level":3,"score":0.3197970986366272},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.21193993091583252},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.20858338475227356},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11687469482421875},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07637262344360352},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/eurheartj/ehad655.2799","doi":"https://doi.org/10.1093/eurheartj/ehad655.2799","is_oa":true,"landing_page_url":"https://doi.org/10.1093/eurheartj/ehad655.2799","pdf_url":"https://academic.oup.com/eurheartj/article-pdf/44/Supplement_2/ehad655.2799/53609648/ehad655.2799.pdf","source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/eurheartj/ehad655.2799","doi":"https://doi.org/10.1093/eurheartj/ehad655.2799","is_oa":true,"landing_page_url":"https://doi.org/10.1093/eurheartj/ehad655.2799","pdf_url":"https://academic.oup.com/eurheartj/article-pdf/44/Supplement_2/ehad655.2799/53609648/ehad655.2799.pdf","source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388596157.pdf","grobid_xml":"https://content.openalex.org/works/W4388596157.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7128070847","https://openalex.org/W3109051854","https://openalex.org/W4388753588","https://openalex.org/W4380795116","https://openalex.org/W3161865957","https://openalex.org/W4415794653","https://openalex.org/W2170210469","https://openalex.org/W4395030209","https://openalex.org/W4403822517","https://openalex.org/W2941139188"],"abstract_inverted_index":{"Abstract":[0],"Introduction":[1],"Hypertriglyceridemia":[2],"leads":[3],"to":[4,9,36,120,126,139,193,278],"endothelial":[5],"dysfunction":[6],"and":[7,12,44,73,123,134,152,176,189,223,231,236,270,292,298,329,341],"contributes":[8],"the":[10,30,53,70,141,160,166,255,262,281,317],"onset":[11],"progression":[13],"of":[14,22,26,76,92,115,130,169,186,202,218,248,320,324,353],"atherosclerosis":[15],"as":[16,18],"well":[17],"an":[19,213],"increased":[20],"risk":[21],"acute":[23],"pancreatitis.":[24],"Inhibition":[25],"Apolipoprotein-CIII":[27],"(APOC3)":[28],"via":[29],"RNA":[31,61],"interference":[32],"mechanism":[33],"is":[34,55,310],"supposed":[35],"reduce":[37],"plasma":[38],"Triglycerides":[39],"(TG)":[40],"levels":[41,185,238,297],"with":[42,64,81,100,163,322],"durable":[43],"high":[45,337],"efficacy.":[46],"RBD5044,":[47,147],"which":[48],"targets":[49],"APOC3":[50,95,122,175,188,208,222,235,269],"mRNA":[51],"in":[52,174,178,288,300,327,332,346,356,362],"liver,":[54],"a":[56,87,101,179,199,245,311,342],"chemically-modified":[57],"double-stranded":[58],"small":[59],"interfering":[60],"(siRNA)":[62],"conjugated":[63],"N-acetylgalactosamine":[65],"(Ribo-GalSTAR).":[66],"Purpose":[67],"To":[68],"investigate":[69],"preclinical":[71,128,142,347],"efficacy":[72,129],"safety":[74,344],"profile":[75,345],"RBD5044.":[77,93,116,131,205],"Methods":[78],"Rhesus":[79],"monkeys":[80,136,162],"spontaneously":[82],"developed":[83],"hypertriglyceridemia":[84],"were":[85,98,137,191,239],"given":[86],"single":[88,102,200,230,246],"subcutaneous":[89],"(sc)":[90],"injection":[91,355],"Humanized":[94],"transgenic":[96,209],"mice":[97],"treated":[99],"dose":[103,201,247,258],"or":[104],"repeated":[105,232,257],"doses":[106],"(once":[107],"every":[108],"two":[109],"weeks":[110],"for":[111,144,221,226,268,272],"three":[112],"doses,":[113],"Q2W\u00d73)":[114],"Plasma":[117],"was":[118],"collected":[119],"quantify":[121],"lipid":[124],"biomarkers":[125],"evaluate":[127,140],"SD":[132],"rats":[133,328],"cynomolgus":[135],"used":[138],"toxicology":[143,156],"subcutaneously":[145],"injected":[146],"including":[148],"single-dose":[149],"toxicity":[150],"studies":[151,307],"4-week":[153],"repeat-dose":[154],"pivotal":[155],"studies.":[157,348],"Results":[158],"In":[159,206],"rhesus":[161],"spontaneous":[164],"hypertriglyceridemia,":[165],"maximum":[167,215],"level":[168,217,264],"inhibition":[170,216,263],"reached":[171],"61.2":[172],"%":[173],"resulted":[177],"TG":[180,190,227,237],"reduction":[181],"by":[182],"53.3%.":[183],"The":[184,234,349],"both":[187,229],"recovered":[192,240],"baseline":[194,279],"till":[195],"Day":[196,242,252],"85":[197],"after":[198,228,244,254],"3":[203,249,260],"mg/kg":[204,326,331],"humanized":[207],"mice,":[210],"RBD5044":[211,284,321,335,354],"achieved":[212],"average":[214],"over":[219],"90%":[220,225],"around":[224],"doses.":[233],"on":[241],"63":[243,253],"mg/kg.":[250],"On":[251],"last":[256],"at":[259,266],"mg/kg,":[261],"remained":[265],"41.6%":[267],"49.4%":[271],"TG,":[273],"hence":[274],"did":[275],"not":[276],"recover":[277],"within":[280],"study":[282],"period.":[283],"also":[285],"showed":[286,308],"reductions":[287],"total":[289],"cholesterol":[290,295,303],"(TC)":[291],"low-density":[293],"lipoprotein":[294,302],"(LDL-C)":[296],"elevations":[299],"high-density":[301],"(HDL-C)":[304],"levels.":[305],"Toxicology":[306],"there":[309],"sufficient":[312],"therapeutic":[313],"margin":[314],"that":[315],"supports":[316],"clinical":[318],"development":[319],"NOAEL":[323],"40":[325],"300":[330],"monkeys.":[333],"Conclusions":[334],"shows":[336],"efficacy,":[338],"long":[339],"duration":[340],"good":[343],"Phase":[350],"I":[351],"trial":[352],"healthy":[357],"volunteers":[358],"has":[359],"been":[360],"initiated":[361],"Australia.Figure":[363],"1Figure":[364],"2":[365]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2023-11-12T00:00:00"}